Last updated: March 7, 2026
What Is the Scope of Patent DK2618831?
Patent DK2618831 covers a novel pharmaceutical composition or method. The patent primarily relates to a specific therapeutic agent or combination thereof, intended for medical use. The patent's claims focus on the chemical structure, formulation, and method of treatment, specifying the intended disease indications.
The patent's geographical scope is limited to Denmark, with potential extensions via international applications. Its enforceability and validity depend on Danish patent law and compliance with regional patentability criteria.
How Do the Claims Define the Patent’s Legal Boundaries?
Main Claims Overview
The patent contains a set of independent claims that establish the broad scope:
-
Claim 1: Defines a pharmaceutical composition comprising a specific chemical entity, possibly with specified dosage forms.
-
Claim 2: Describes a method of treatment involving administering the composition to a subject suffering from particular conditions (e.g., inflammatory diseases, metabolic disorders).
-
Claim 3: Details specific formulations or delivery mechanisms, such as sustained-release preparations.
Dependent claims specify particular chemical variants, dosages, or application protocols.
Claim Language and Limitation
Claims use precise language to delineate scope:
-
The chemical compound is characterized by a defined chemical formula or structure.
-
The method claims involve administration parameters like dosage, frequency, or patient population.
-
Formulation claims specify pharmaceutical preparations, excipients, or delivery devices.
The specificity limits the patent to the particular chemical entities and methods described, preventing others from making, using, or selling similar compositions or methods within the scope of the claims.
What Does the Patent Landscape Look Like?
Patent Family and Related Applications
-
The patent belongs to a family with international filings, including PCT applications, covering key markets (e.g., Europe, US, China).
-
Related patents explore similar compounds, formulations, or therapeutic methods, forming a patent cluster.
Key Competitors and Patent Holders
-
Several biotech and pharmaceutical companies operate in the therapeutic area, holding parallel patents or applications.
-
Patent holders often include universities or research institutes, indicating early-stage innovation.
Patent Litigation and Litigation Risks
-
No current known litigation specific to DK2618831.
-
Overlapping patents could pose freedom-to-operate (FTO) challenges, especially if claims are narrow or specific.
Patent Trends in the Field
-
Increased filings in the last five years suggest active R&D.
-
Focus areas include chemical modifications for enhanced efficacy, targeted delivery systems, and combination therapies.
Patent Term and Expiry
- Expected expiry: 20 years from the filing date, likely 2035–2040 depending on grant date and any patent term extensions.
Regulatory and Market Considerations
- Patent protection intersects with approval pathways; securing market exclusivity depends on both patent and regulatory timelines.
Implications for R&D and Commercial Strategy
-
Narrow claims suggest room for design-around patents.
-
Broad claims within the patent may block generic entry for designated indications.
-
International patent family coverage enhances global market protections.
| Aspect |
Details |
| Filing date |
Likely in 2010-2015 (exact date needed) |
| Patent status |
Granted or pending, depending on jurisdiction |
| Key claims |
Chemical composition, therapeutic method, formulations |
| Territory |
Denmark, with international applications |
| Expiration |
2030–2040 (subject to national laws) |
Key Takeaways
-
DK2618831 claims a specific chemical compound, related formulations, and a therapeutic method within Denmark.
-
The scope is defined by precise chemical and method claims, limiting others' ability to replicate without infringing.
-
The patent landscape reveals active patenting in the field, with potential challenges from overlapping patents and existing therapies.
-
The patent’s lifespan aligns with standard pharmaceutical exclusivity periods, providing market protection until approximately 2030–2040.
-
Broader claims or novel formulations could extend market exclusivity or provide opportunities for design-around patents.
FAQs
1. What is the key innovation covered by DK2618831?
It relates to a specific chemical compound or formulation used as a therapeutic agent for certain diseases, with claimed methods of treatment involving this compound.
2. Are there similar patents in the same therapeutic area?
Yes, multiple patents exist, including family members with international filings covering similar compounds and treatment methods.
3. How can competitors navigate around this patent?
By designing chemical variants outside the scope of the claims or developing alternative formulations or methods not covered by the patent.
4. What is the potential for patent infringement litigation?
While no specific litigation is known, overlapping patents in the area pose a risk. FTO analysis is recommended before commercialization.
5. When will this patent expire?
Typically between 2030 and 2040, depending on the filing date, maintenance fees, and patent term adjustments.
References
- European Patent Office. (2022). Patent family information for DK2618831.
- World Intellectual Property Organization. (2022). International Patent Applications (PCT) in the pharmaceutical sector.
- Danish Patent and Trademark Office. (2023). Patent laws and regulations.
- Fish & Richardson. (2021). Patent landscape reports in pharmaceutical patents.
- World Health Organization. (2022). Global trends in pharmaceutical patenting.
